192 related articles for article (PubMed ID: 30565037)
1. ASO Author Reflections: Can We Predict an Unsalvageable Recurrence Following Colorectal Liver Metastasectomy?
Okuno M; Conrad C
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):549-550. PubMed ID: 30565037
[No Abstract] [Full Text] [Related]
2. RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases.
Brudvik KW; Mise Y; Chung MH; Chun YS; Kopetz SE; Passot G; Conrad C; Maru DM; Aloia TA; Vauthey JN
Ann Surg Oncol; 2016 Aug; 23(8):2635-43. PubMed ID: 27016292
[TBL] [Abstract][Full Text] [Related]
3. ASO Author Reflections: Prognostic Impact of Budding Grade on Patients with Residual Liver Recurrence of Colorectal Cancer After Initial Hepatectomy.
Noro T
Ann Surg Oncol; 2020 Dec; 27(13):5208. PubMed ID: 32770295
[No Abstract] [Full Text] [Related]
4. BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy.
Teng HW; Huang YC; Lin JK; Chen WS; Lin TC; Jiang JK; Yen CC; Li AF; Wang HW; Chang SC; Lan YT; Lin CC; Wang HS; Yang SH
J Surg Oncol; 2012 Aug; 106(2):123-9. PubMed ID: 22331825
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary metastasectomy in colorectal cancer patients with previously resected liver metastasis: pooled analysis.
Salah S; Ardissone F; Gonzalez M; Gervaz P; Riquet M; Watanabe K; Zabaleta J; Al-Rimawi D; Toubasi S; Massad E; Lisi E; Hamed OH
Ann Surg Oncol; 2015; 22(6):1844-50. PubMed ID: 25326396
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations.
Passot G; Chun YS; Kopetz SE; Overman MJ; Conrad C; Aloia TA; Vauthey JN
Eur J Surg Oncol; 2016 Sep; 42(9):1378-84. PubMed ID: 27358198
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.
Corsini EM; Mitchell KG; Mehran RJ; Rice DC; Sepesi B; Walsh GL; Swisher SG; Roth JA; Hofstetter WL; Vaporciyan AA; Morris VK; Antonoff MB
J Surg Oncol; 2019 Sep; 120(4):729-735. PubMed ID: 31290159
[TBL] [Abstract][Full Text] [Related]
8. EGFR, BRAF and KRAS status in patients undergoing pulmonary metastasectomy from primary colorectal carcinoma: a prospective follow-up study.
Schweiger T; Hegedüs B; Nikolowsky C; Hegedüs Z; Szirtes I; Mair R; Birner P; Döme B; Lang G; Klepetko W; Ankersmit HJ; Hoetzenecker K
Ann Surg Oncol; 2014 Mar; 21(3):946-54. PubMed ID: 24281417
[TBL] [Abstract][Full Text] [Related]
9. KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma.
Siyar Ekinci A; Demirci U; Cakmak Oksuzoglu B; Ozturk A; Esbah O; Ozatli T; Celik B; Budakoglu B; Turker I; Bal O; Turan N
J BUON; 2015; 20(1):128-35. PubMed ID: 25778307
[TBL] [Abstract][Full Text] [Related]
10. RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.
Okuno M; Goumard C; Kopetz S; Vega EA; Joechle K; Mizuno T; Omichi K; Tzeng CD; Chun YS; Vauthey JN; Conrad C
Ann Surg Oncol; 2018 Aug; 25(8):2457-2466. PubMed ID: 29786130
[TBL] [Abstract][Full Text] [Related]
11. ASO Author Reflections: Characterizing the Impact of RAS Mutation Location on Outcomes for Colorectal Liver Metastases.
Saadat LV; D'Angelica MI
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):867-868. PubMed ID: 32725531
[No Abstract] [Full Text] [Related]
12. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
[TBL] [Abstract][Full Text] [Related]
13. ASO Author Reflections: Ras-p53 Cooperativity Predicts Recurrence Patterns After Resection of Colorectal Liver Metastases with Adjuvant Local and Systemic Chemotherapy.
Narayan RR; Datta J; D'Angelica MI
Ann Surg Oncol; 2022 Nov; 29(12):7589-7590. PubMed ID: 35773562
[No Abstract] [Full Text] [Related]
14. KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: a biomarker of cancer biology or a byproduct of patient selection?
Søreide K; Sandvik OM; Søreide JA
Cancer; 2014 Dec; 120(24):3862-5. PubMed ID: 25155780
[No Abstract] [Full Text] [Related]
15. Survival after lung metastasectomy for colorectal cancer: importance of previous liver metastasis as a prognostic factor.
Zabaleta J; Aguinagalde B; Fuentes MG; Bazterargui N; Izquierdo JM; Hernández CJ; Enriquez-Navascués JM; Emparanza JI
Eur J Surg Oncol; 2011 Sep; 37(9):786-90. PubMed ID: 21723689
[TBL] [Abstract][Full Text] [Related]
16. [Liver and lung metastases of colorectal cancer. Long-term survival and prognostic factors].
Sponholz S; Bölükbas S; Schirren M; Oguzhan S; Kudelin N; Schirren J
Chirurg; 2016 Feb; 87(2):151-6. PubMed ID: 26016711
[TBL] [Abstract][Full Text] [Related]
17. K-Ras and MSI: potential markers of both patient prognosis and treatment efficacy.
Turaga K; Shibata D
Ann Surg Oncol; 2010 Feb; 17(2):354-5. PubMed ID: 19936842
[No Abstract] [Full Text] [Related]
18. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
[TBL] [Abstract][Full Text] [Related]
19. Repeated Resections of Hepatic and Pulmonary Metastases from Colorectal Cancer Provide Long-Term Survival.
Bellier J; De Wolf J; Hebbar M; Amrani ME; Desauw C; Leteurtre E; Pruvot FR; Porte H; Truant S
World J Surg; 2018 Apr; 42(4):1171-1179. PubMed ID: 28948336
[TBL] [Abstract][Full Text] [Related]
20. A competing risk for nomogram of the role of metastasectomy in patients with colorectal cancer and liver metastases.
Dai S; Zhao W; Yue L; Qian X
Asian J Surg; 2023 Jun; 46(6):2468-2471. PubMed ID: 36567218
[No Abstract] [Full Text] [Related]
[Next] [New Search]
